In our CLL cohort, we observed high expression levels of CXCR3, CXCR5, CCR10, and CD62L on CD5high cells and high CXCR4 on CD5low cells, which is in line with a previous study [8]. The gene discussed is SELL; the disease is B-cell chronic lymphocytic leukemia.